| ORQIS Medical Corporation |
|
|
14 Orchard Road, Suite 100
Lake Forest, CA 92630 USA
phone:
(949) 707-5890
fax:
(949) 707-5894 |
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
www.orqis.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Treatment of congestive heart failure. |
 |
| Management |
| Kenneth Charhut, President and Chief Executive Officer; Marvin A. Konstam, M.D., Medical Director; John M. Markovich, Chief Financial Officer; Irene Parker, Vice President, Regulatory and Clinical Programs; Michael Scott, Ph.D., Vice President of Research and Development |
|
|
|
|
| Keywords |
| congestive heart failure, canion system, MOMENTUM trial, EXELERAS system, implantable, adv2007, advamed |
|
|
|
|
Description |
| ORQIS Medical is and emerging company developing novel continuous aortic flow augmentation (CAFA) devices to treat underlying mechanisms heart failure. CAFA is a proprietary approach to treat disordered aortic flow in heart failure by changing blood flow dynamics in the descending aorta. |
 |
| Products / Services |
The company is developing two devices to treat heart failure. The percutaneous Cancion® System for decompensated heart failure is CE marked and being sold in select markets. The implantable Exeleras® System for chronic heart failure is in final stages of pre-clinical testing to ready the product for first clinical use.
|
 |
 |
|
|
|
|